2016 Midkine Symposium Program

  9:00-10:15am            SESSION 5: MK & PTN in Angiogenesis & Bone

 Session Moderator:     Associate Professor Graham Robertson



Professor Evangelia Papadimitriou, University of Patras, Patras, Greece


PLENARY 2: Pleiotrophin and its receptor RPTP beta/zeta as angiogenesis regulators  

More Details 



Dr Astrid LiedertUniversity Medical Centre Ulm, Germany

Anti-midkine antibody treatment accelerates Fracture healing in mice 

More Details 

 10:15am-11:00am       Morning tea and poster viewing

 11:00am-12:15pm       SESSION 6: Midkine in cardiovascular disease                                   

 Session Moderator:     Maria Halasz



Professor Peter FerdinandySemmelweis Uni and PharmaHungary, Budapest Hungary

Midkine protein therapeutics in preclincial models of cardiac muscle injury

More Details

 11:30am -12:00pm


Dr Ulrich Grabmaier, Ludwig-Maximilians-University, Munich, Germany

Targeting the N-terminal Domain of Midkine attenuates leukocyte infiltration and cardiac fibrosis & dysfunction in experimental autoimmune Myocarditis

More Details 



Ms Sharron HallCellmid Ltd & Hunter MRI, Newcastle, Australia

Midkine levels in acute and prolonged Exercise by Elite Athletes

More Details 

12:15pm-1:30pm         Lunch and networking

 1:30pm-2:50pm         SESSION 7:  Midkine and cancer

 Session Moderator:     Joseph Haklani



Professor Guillermo VelascoComplutense Universidad, Madrid, Spain

Role of the Midkine/ALK axis in gliomas

More Details 



Dr Margarete KargUniversity Hospital Erlangen, Erlangen, Germany

Midkine expression in Uveal Cancer

More Details 



Associate Professor Mine ErguvenIstanbul Aydin University, Istanbul, Turkey

Indomethicin decreased Midkine levels in the treatment of Glioblastoma

More Details



Dr Jeremy ClarkNorwich Medical School, University of East Anglia, UK

Analysis of Midkine protein and mRNA in Prostate Cancer Patient Urine Samples

More Details

 3:00pm-3:30pm          Afternoon tea and poster viewing

 3:30pm-5:00pm         SESSION 7 (Cont.): Midkine and cancer                           

 Session Moderator:     Joseph Haklani



Professor Ayhan BilirZirve University, Gazientep, Turkey

Loss of Angiocidin expression increases Midkine in Endometrial cancer cells

More Details 



Dr David DavilaComplutense Universidad, Madrid, Spain

Targeting the MDK/ALK axis as a potential therapeutic strategy in gliomas

More Details



Professor Richard BarkerFounding Director, Centre for the Advancement of Sustainable Medical Innovation, Oxford UK

PLENARY 3: Bioscience - lost in translation? How precision medicine will close the innovation gap

More Details

PANEL DISCUSSION: Therapeutic and clinical opportunities for midkine

Panelists: Dr Fintan Walton, Professor Richard Barker, Dr Vicki Campbell, Associate Professor Graham Robertson

 5:30pm Onward         Symposium Dinner